PIP
AMGN icon

Peachtree Investment Partners’s Amgen AMGN Stock Holding History

Peachtree Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208K Sell
592
-40
-6% -$14.3K 0.08% 92
2025
Q4 		$207K Buy
+632
New +$200K 0.07% 91
2024
Q4 		– Sell
-642
Closed -$207K – 117
2024
Q3 		$207K Buy
+642
New +$210K 0.08% 83

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Peachtree Investment Partners's AMGN Position: Q1 2026 in Review

Peachtree Investment Partners reduced its Amgen (AMGN) stake by 6.3% in Q1 2026, selling an estimated $14.3K and leaving 592 shares worth $208K. The position accounts for 0.08% of the portfolio, ranked #92.

Peachtree Investment Partners first reported a position in AMGN in Q3 2024 and has held it in 3 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Peachtree Investment Partners held 592 shares of Amgen worth $208K as of Q1 2026.
  • Peachtree Investment Partners sold 40 Amgen shares in Q1 2026, an estimated $14.3K.
  • Amgen made up 0.08% of Peachtree Investment Partners's portfolio in Q1 2026, its #92 holding.
  • Peachtree Investment Partners first reported a position in Amgen in Q3 2024 and has held it in 3 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Peachtree Investment Partners's 13F filing for Q1 2026, filed 8 May 2026.